Page last updated: 2024-08-25

broxaterol and Lung Diseases, Obstructive

broxaterol has been researched along with Lung Diseases, Obstructive in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boni, E; Filippi, B; Giustina, A; Grassi, V; Malerba, M; Politi, A; Romagnoni, G; Tantucci, C1
Duranti, R; Gigliotti, F; Gorini, M; Gurrieri, G; Scano, G1
Crotti, P; Fracchia, C; Gurrieri, G; Nava, S; Rampulla, C1
Bründler, H; Godly, R; Herzog, H; Imhof, E; Perruchoud, AP1
Cafaggi, R; D'Onofrio, V; Giosuè, S; Guerrini, P; Perrone, N; Scano, M1
Casali, L; Colombo, ML; Manazza, P; Rossi, A; Zoia, MC1

Trials

5 trial(s) available for broxaterol and Lung Diseases, Obstructive

ArticleYear
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1994, Volume: 49, Issue:5

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged

1994
Effects of intravenous broxaterol on respiratory drive and neuromuscular coupling in COPD patients.
    The European respiratory journal, 1993, Volume: 6, Issue:3

    Topics: Adrenergic beta-Agonists; Double-Blind Method; Electromyography; Heart Rate; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Respiratory Function Tests; Respiratory Mechanics; Respiratory Muscles

1993
Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction.
    Chest, 1992, Volume: 101, Issue:1

    Topics: Adrenergic beta-Agonists; Aged; Carbon Dioxide; Double-Blind Method; Humans; Isoxazoles; Lung Diseases, Obstructive; Middle Aged; Muscle Contraction; Oxygen; Respiratory Mechanics; Respiratory Muscles

1992
Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Respiration; international review of thoracic diseases, 1987, Volume: 51, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Double-Blind Method; Female; Hemodynamics; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Random Allocation; Respiratory Function Tests

1987
A comparison of the bronchodilator effects of broxaterol and salbutamol.
    International journal of clinical pharmacology, therapy, and toxicology, 1988, Volume: 26, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Respiratory Function Tests; Time Factors

1988

Other Studies

1 other study(ies) available for broxaterol and Lung Diseases, Obstructive

ArticleYear
[Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    La Clinica terapeutica, 1987, Apr-15, Volume: 121, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Vital Capacity

1987